Zobrazeno 1 - 10
of 79
pro vyhledávání: '"R.S.B. Stucchi"'
Publikováno v:
Brazilian Journal of Medical and Biological Research, Vol 49, Iss 11 (2016)
Hepatitis C virus (HCV) genotype 3 is responsible for 30.1% of chronic hepatitis C infection cases worldwide. In the era of direct-acting antivirals, these patients have become one of the most challenging to treat, due to fewer effective drug options
Externí odkaz:
https://doaj.org/article/913e27be570e404bb4193a315d0bbd09
Autor:
L.C. Mendes, P.A. Ferreira, N. Miotto, L. Zanaga, E. Gonçales, M.S. Lazarini, F.L. Gonçales Júnior, R.S.B. Stucchi, A.G. Vigani
Publikováno v:
Brazilian Journal of Medical and Biological Research, Vol 49, Iss 9 (2016)
Although long regarded as the gold standard for liver fibrosis staging in chronic hepatitis C (CHC), liver biopsy (LB) implies both the risk of an invasive procedure and significant variability. The aim of this study was to evaluate the diagnostic pe
Externí odkaz:
https://doaj.org/article/edf971cd27da45fc9737a664f90411d3
Autor:
N. Miotto, L.C. Mendes, L.P. Zanaga, E.S.L. Goncales, M.S.K. Lazarini, M.N. Pedro, F.L. Goncales Jr., R.S.B. Stucchi, A.G. Vigani
Publikováno v:
Brazilian Journal of Medical and Biological Research, Vol 49, Iss 7 (2016)
The aim of this study was to determine risk factors for adverse events (AE)-related treatment discontinuation and severe anemia among patients with chronic hepatitis C virus (HCV) genotype 1 infection, treated with first-generation protease inhibitor
Externí odkaz:
https://doaj.org/article/76d67a772a4947d2b94b005d107ab100
Publikováno v:
Brazilian Journal of Medical and Biological Research, Vol 41, Iss 10, Pp 890-895 (2008)
Enterococcus spp bacteremia is associated with high mortality and the appearance of high-level gentamicin resistance (HLGR) created additional challenges for the treatment of these infections. We evaluated the epidemiological and clinical characteris
Externí odkaz:
https://doaj.org/article/f142b7bef705488bb8060197c4ed996f
Autor:
L.P. Zanaga, A.G. Vigani, R.N. Angerami, A. Giorgetti, C.A.F. Escanhoela, E.C. Ataíde, I.F.S.F. Boin, R.S.B. Stucchi
Publikováno v:
Brazilian Journal of Medical and Biological Research, Vol 50, Iss 1
Recurrent hepatitis C after orthotopic liver transplantation (OLT) is universal and can lead to graft failure and, consequently, reduced survival. Hepatitis C treatment can be used to prevent these detrimental outcomes. The aim of this study was to d
Externí odkaz:
https://doaj.org/article/ef1f9ff3e3b74e5cbae7c4ef12d33bef
Publikováno v:
Brazilian Journal of Medical and Biological Research, Vol 52, Iss 8
Recurrent hepatitis C (HCV) after liver transplantation (LT) is an important cause of morbidity and mortality. Antiviral treatment is recommended to avoid unfavorable outcomes. Direct-acting antivirals (DAA) have transformed HCV treatment, with highe
Externí odkaz:
https://doaj.org/article/d97caaecc8284423810b995180058c74
Publikováno v:
Brazilian Journal of Medical and Biological Research, Vol 49, Iss 11
Hepatitis C virus (HCV) genotype 3 is responsible for 30.1% of chronic hepatitis C infection cases worldwide. In the era of direct-acting antivirals, these patients have become one of the most challenging to treat, due to fewer effective drug options
Externí odkaz:
https://doaj.org/article/68bbe78487cf4cfbb9d35415636b1966
Publikováno v:
Transplantation Proceedings. 45:1122-1125
Liver transplantation is a complex procedure that interferes with multiple body functions and can cause several complications. Studies have shown varying incidences of neurological complications (8% to 47%) including encephalopathy, as well as cerebr
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
European Psychiatry. 33:S397-S398
Relevant emotional and behavioural reactions are associated with diagnosis and treatment of hepatitis C that can impair adherence to medical management. Hepatitis C accounts for significant number of both – liver transplants and deaths. Treatment h